Oric Pharmaceuticals, Inc. (23)
Browse by Contract Category
Contracts
-
License and Collaboration Agreement between the registrant and Voronoi, Inc., dated as of October 19, 2020
(Filed With SEC on May 9, 2022)
-
License Agreement between the registrant and Mirati Therapeutics, Inc., dated as of August 3, 2020
(Filed With SEC on May 9, 2022)
-
Amended and Restated Outside Director Compensation Policy
(Filed With SEC on March 21, 2022)
-
Description of the Registrants securities
(Filed With SEC on March 21, 2022)
-
2020 Employee Stock Purchase Plan and forms of agreement thereunder
(Filed With SEC on November 8, 2021)
-
First Amendment to Lease between the Registrant and Britannia Pointe Grand Limited Partnership, dated August 12, 2021
(Filed With SEC on August 16, 2021)
-
2022 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements
(Filed With SEC on March 4, 2022)
-
Open Market Sale AgreementSM, dated May 6, 2021, by and between ORIC Pharmaceuticals, Inc. and Jefferies LLC
(Filed With SEC on May 6, 2021)
-
Form of Underwriting Agreement, including Form of Lock-up Agreement
(Filed With SEC on November 10, 2020)
-
2020 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on April 20, 2020)
-
Outside Director Compensation Policy
(Filed With SEC on April 20, 2020)
-
2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on April 20, 2020)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on April 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on April 20, 2020)
-
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
(Filed With SEC on February 28, 2020)
-
Lease between the Registrant and Britannia Pointe Grand Limited Partnership, dated June 5, 2015
(Filed With SEC on February 28, 2020)
-
Change in Control and Severance Policy
(Filed With SEC on February 28, 2020)
-
Executive Incentive Compensation Plan
(Filed With SEC on February 28, 2020)
-
Employment Letter between the Registrant and Dominic Piscitelli
(Filed With SEC on February 28, 2020)
-
Employment Letter between the Registrant and Pratik Multani, M.D
(Filed With SEC on February 28, 2020)
-
Employment Letter between the Registrant and Jacob M. Chacko, M.D
(Filed With SEC on February 28, 2020)
-
2014 Equity Incentive Plan, as amended, and forms of agreement thereunder
(Filed With SEC on February 28, 2020)
-
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated June 4, 2019
(Filed With SEC on February 28, 2020)